AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+8.57%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$11.2B
AUM Growth
+$642M
(+6.1%)
Cap. Flow
-$94.3M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
52.34%
Holding
1,116
New
76
Increased
314
Reduced
582
Closed
97
Top Buys
| 1 |
Enterprise Products Partners
EPD
|
+$60.6M |
| 2 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$56.7M |
| 3 |
Cheniere Energy
CQP
|
+$54.8M |
| 4 |
Western Midstream Partners
WES
|
+$47.3M |
| 5 |
Albemarle
ALB
|
+$27M |
Top Sells
| 1 |
SHLX
Shell Midstream Partners, L.P.
SHLX
|
+$280M |
| 2 |
Hewlett Packard
HPE
|
+$29.9M |
| 3 |
Exxon Mobil
XOM
|
+$29M |
| 4 |
Lockheed Martin
LMT
|
+$28.8M |
| 5 |
Valero Energy
VLO
|
+$27.6M |
Sector Composition
| 1 | Energy | 63.96% |
| 2 | Technology | 5.43% |
| 3 | Healthcare | 4.22% |
| 4 | Consumer Discretionary | 3.76% |
| 5 | Financials | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Radian Group
RDN
$4.77B
| $752K | 0.01% |
39,441
+4,041
| +11% | +$77.1K |
|
527
Quest Diagnostics
DGX
$20.4B
| $751K | 0.01% |
4,803
-273
| -5% | -$42.7K |
|
528
Roku
ROKU
$14.6B
| $745K | 0.01% |
18,305
-120
| -0.7% | -$4.88K |
|
529
StepStone Group
STEP
$4.86B
| $743K | 0.01% |
29,500
-2,200
| -7% | -$55.4K |
|
|
IMGN
530
DELISTED
Immunogen Inc
IMGN
| $742K | 0.01% |
149,640
+29,172
| +24% | +$145K |
|
531
CVS Health
CVS
$91B
| $741K | 0.01% |
7,948
-705
| -8% | -$65.7K |
|
532
Invesco
IVZ
$9.81B
| $738K | 0.01% |
41,007
+4,207
| +11% | +$75.7K |
|
533
Aclaris Therapeutics
ACRS
$231M
| $712K | 0.01% |
+45,205
| New | +$712K |
|
|
BLU
534
DELISTED
BELLUS Health Inc.
BLU
| $698K | 0.01% |
84,953
+16,578
| +24% | +$136K |
|
535
Fulton Financial
FULT
$3.54B
| $697K | 0.01% |
41,442
-9,059
| -18% | -$152K |
|
536
PetMed Express
PETS
$58.9M
| $693K | 0.01% |
39,176
-8,566
| -18% | -$152K |
|
537
Booking.com
BKNG
$181B
| $685K | 0.01% |
340
-95
| -22% | -$191K |
|
538
Elevance Health
ELV
$69.4B
| $679K | 0.01% |
1,323
-73
| -5% | -$37.4K |
|
539
Crinetics Pharmaceuticals
CRNX
$3.44B
| $668K | 0.01% |
36,477
+7,151
| +24% | +$131K |
|
540
Regenxbio
RGNX
$479M
| $666K | 0.01% |
29,345
+5,713
| +24% | +$130K |
|
541
Opko Health
OPK
$1.13B
| $656K | 0.01% |
524,592
+103,188
| +24% | +$129K |
|
542
Enanta Pharmaceuticals
ENTA
$190M
| $655K | 0.01% |
14,079
+2,794
| +25% | +$130K |
|
|
MRO
543
DELISTED
Marathon Oil Corporation
MRO
| $654K | 0.01% |
24,162
-1,966
| -8% | -$53.2K |
|
|
RC
544
Ready Capital
RC
$720M
| $653K | 0.01% |
58,610
-12,807
| -18% | -$143K |
|
545
Deere & Co
DE
$130B
| $645K | 0.01% |
1,505
+104
| +7% | +$44.6K |
|
546
Pliant Therapeutics
PLRX
$107M
| $639K | 0.01% |
+33,073
| New | +$639K |
|
547
Nice
NICE
$8.83B
| $632K | 0.01% |
3,287
-798
| -20% | -$153K |
|
548
Annaly Capital Management
NLY
$14.2B
| $629K | 0.01% |
29,828
-6,518
| -18% | -$137K |
|
549
Ecopetrol
EC
$18.8B
| $628K | 0.01% |
+60,000
| New | +$628K |
|
550
Reynolds Consumer Products
REYN
$4.85B
| $627K | 0.01% |
20,902
+2,172
| +12% | +$65.1K |
|